A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)	Advanced Solid Tumor; Metastatic Solid Tumors	Active, not recruiting	Phase 2	2026-09-24		NCT06660654

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daiichi Sankyo	144
Merck Sharp & Dohme LLC	650

48 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Centre	Nagoya	Japan	1
AO per lEmergenza Cannizzaro	Catania	Italy	1
Asan Medical Center	Seoul	South Korea	338
Astera Cancer Care	East Brunswick	United States	38
Azienda Ospedaliera S Maria	Terni	Italy	1
Cario - Centre Armoricain de Radiothérapie, Imagerie Médicale Et Oncologie	Plérin	France	2
Centre Georges-François Leclerc	Dijon	France	15
Centre Leon Berard	Lyon	France	70
Centre Oscar Lambret	Lille	France	1
Clinical Research Alliance	Westbury	United States	14
Federico II Hospital	Naples	Italy	1
Fondazione IRCCS Istituto Nazionale dei Tumori	Milan	Italy	1
François Baclesse Center	Caen	France	1
Grp Hsp Diac Croix Saint Simon	Paris	France	1
Gustave Roussy	Villejuif	France	48
Herlev og Gentofte Hosp	Copenhagen	Denmark	1
Hospital 12 Octubre	Madrid	Spain	1
Hospital de Sant Pau	Barcelona	Spain	2
Hospital Universitario de A Coruña	A Coruña	Spain	9
Hospital Universitario Virgen de La Victoria	Málaga	Spain	79
Hunan Cancer Hospital	Changsha	China	39
Hyogo Cancer Center	Akashi	Japan	1
ICO - Site René Gauducheau	Saint-Herblain	France	5
Institut Claudius Regaud	Toulouse	France	7
IRCCS Dino Amadori - IRST	Meldola	Italy	1

Clinical trials